122 related articles for article (PubMed ID: 8971079)
21. Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants.
Mett V; Shamloul AM; Hirai H; Zhou Z; Notkins A; Yusibov V
Transgenic Res; 2007 Feb; 16(1):77-84. PubMed ID: 17103024
[TBL] [Abstract][Full Text] [Related]
22. IA-2 and IA-2 beta are major autoantigens in IDDM and the precursors of the 40 kDa and 37 kDa tryptic fragments.
Notkins AL; Lu J; Li Q; VanderVegt FP; Wasserfall C; Maclaren NK; Lan MS
J Autoimmun; 1996 Oct; 9(5):677-82. PubMed ID: 8933284
[TBL] [Abstract][Full Text] [Related]
23. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes.
Kawasaki E; Yu L; Rewers MJ; Hutton JC; Eisenbarth GS
Diabetes; 1998 May; 47(5):733-42. PubMed ID: 9588444
[TBL] [Abstract][Full Text] [Related]
24. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
[TBL] [Abstract][Full Text] [Related]
25. Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes.
Farilla L; Tiberti C; Luzzago A; Yu L; Eisenbarth GS; Cortese R; Dotta F; Di Mario U
Eur J Immunol; 2002 May; 32(5):1420-7. PubMed ID: 11981830
[TBL] [Abstract][Full Text] [Related]
26. Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in Type-I diabetes.
Morgenthaler NG; Löbner K; Morgenthaler UY; Christie MR; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Sep; 30(9):559-64. PubMed ID: 9808324
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
28. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
29. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
[TBL] [Abstract][Full Text] [Related]
30. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
[TBL] [Abstract][Full Text] [Related]
31. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
Leslie RD; Atkinson MA; Notkins AL
Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
[No Abstract] [Full Text] [Related]
32. Cellular immune response to diverse islet cell antigens in IDDM.
Durinovic-Bellò I; Hummel M; Ziegler AG
Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to the protein tyrosine phosphatases IAR and IA-2 are associated with progression to insulin-dependent diabetes (IDDM) in first-degree relatives at-risk for IDDM.
Schmidli RS; Colman PG; Cui L; Yu WP; Kewming K; Jankulovski C; Harrison LC; Pallen CJ; DeAizpurua HJ
Autoimmunity; 1998; 28(1):15-23. PubMed ID: 9754810
[TBL] [Abstract][Full Text] [Related]
34. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
35. Growth and autoantibodies to IA-2 in children with type 1 diabetes.
Cianfarani S; Bonfanti R; Manca Bitti ML; Chiumello G; Boscherini B
Lancet; 2000 Oct; 356(9240):1521. PubMed ID: 11081554
[No Abstract] [Full Text] [Related]
36. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs.
Kawasaki E; Yu L; Gianani R; Verge CF; Babu S; Bonifacio E; Eisenbarth GS
J Clin Endocrinol Metab; 1997 Feb; 82(2):375-80. PubMed ID: 9024221
[TBL] [Abstract][Full Text] [Related]
37. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterisation of a human monoclonal autoantibody to the islet cell autoantigen IA-2.
Ananieva-Jordanova R; Evans M; Nakamatsu T; Premawardhana LD; Sanders J; Powell M; Chen S; McGrath V; Belton C; Arnold C; Baker S; Betterle C; Zanchetta R; Smith BR; Furmaniak J
J Autoimmun; 2005 Jun; 24(4):337-45. PubMed ID: 15869863
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to ICA512/IA-2 in rodent models of IDDM.
Myers MA; Laks MR; Feeney SJ; Mandel TE; Koulmanda M; Bone A; Barley J; Rowley MJ; Mackay IR
J Autoimmun; 1998 Jun; 11(3):265-72. PubMed ID: 9693975
[TBL] [Abstract][Full Text] [Related]
40. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
